Healthcare
Live Price
Offline$1.70
-3.41% today
1Y Change
-93.17%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 245 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Purple Biotech Ltd. (PPBT) is a Healthcare stock with listed on NASDAQ. The stock last traded around $1.70 and down 93.2% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -24967.9%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -24967.9%, free cash flow +61.4% with operating margin 0.0% and ROIC -295.3%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines PPBT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PPBT
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
PPBT Max Drawdown
-94.45%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for PPBT and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.